In spite of this explicit prognostic information, Ki-67 measurement remains inconsistent and irreproducible between patients, limiting updates to current guidelines surrounding the routine inclusion of Ki-67 staining in standard breast cancer immuno-histochemical workup. The gene discussed is MKI67; the disease is breast carcinoma.